Christopher Godina

1 – 10 of 12

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/ch3385go?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2025
Mark Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort
Godina, Christopher ^LU ; Rosendahl, Ann H ^LU ; Gonçalves de Oliveira, Kelin ^LU ; Khazaei, Somayeh ^LU ; Björner, Sofie ^LU ; Jirström, Karin ^LU ; Isaksson, Karolin ^LU ; Pollak, Michael N and Jernström, Helena ^LU (2025) In Carcinogenesis 46(2).
- Contribution to journal › Article
2024
Mark Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
Lindgren, Hampus ^LU ; Ademi, David ^LU ; Godina, Christopher ^LU ; Tryggvadottir, Helga ^LU ; Isaksson, Karolin ^LU and Jernström, Helena ^LU (2024) In Cancer Causes and Control 35(6). p.907-919
- Contribution to journal › Article
Mark Metabolic and angiogenic biomarkers in breast cancer: potential clinical implications of host–tumor interactions
Godina, Christopher ^LU (2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
Mark Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
Godina, Christopher ^LU ; Belting, Mattias ^LU ; Vallon-Christersson, Johan ^LU ; Isaksson, Karolin ^LU ; Bosch, Ana ^LU and Jernström, Helena ^LU (2024) In Scientific Reports 14(1).
- Contribution to journal › Article
Mark High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
Godina, Christopher ^LU ; Khazaei, Somayeh ^LU ; Belting, Mattias ^LU ; Vallon-Christersson, Johan ^LU ; Nodin, Björn ^LU ; Jirström, Karin ^LU ; Isaksson, Karolin ^LU ; Bosch, Ana ^LU and Jernström, Helena ^LU (2024) In PLoS ONE 19(7). p.1-21
- Contribution to journal › Article
Mark Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression
Godina, Christopher ^LU ; Pollak, Michael N. and Jernström, Helena ^LU (2024) In NPJ precision oncology 8(1).
- Contribution to journal › Article
Mark A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
Faraj Tabrizi, Schayan ; Mei, Wenbin ; Godina, Christopher ^LU ; Lovisa, Anthea F. ; Isaksson, Karolin ^LU ; Jernström, Helena ^LU and Tavazoie, Sohail F. (2024) In Cell 188(2). p.28-389
- Contribution to journal › Article
2023
Mark Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
Godina, Christopher ^LU ; Tryggvadottir, Helga ^LU ; Bosch, Ana ^LU ; Borgquist, Signe ^LU ; Belting, Mattias ^LU ; Isaksson, Karolin ^LU and Jernström, Helena ^LU (2023) In Breast Cancer Research and Treatment 199(2). p.335-347
- Contribution to journal › Article
Mark Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
Jujic, Amra ^LU ; Godina, Christopher ^LU ; Belting, Mattias ^LU ; Melander, Olle ^LU ; Juul Holst, Jens ; Ahlqvist, Emma ^LU ; Gomez, Maria F ^LU ; Nilsson, Peter M ^LU ; Jernström, Helena ^LU and Magnusson, Martin ^LU (2023) In Scientific Reports 13. p.1-11
- Contribution to journal › Article
2022
Mark Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
Godina, Christopher ^LU ; Indira Chandran, Vineesh ^LU ; Barbachowska, Magdalena ^LU ; Tryggvadottir, Helga ^LU ; Nodin, Björn ^LU ; Visse, Edward ^LU ; Borgquist, Signe ^LU ; Jirström, Karin ^LU ; Isaksson, Karolin ^LU and Bosch, Ana ^LU , et al. (2022) In Translational Oncology 22.
- Contribution to journal › Article

« previous
1
2
next »